Verition Fund Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.69M | Buy |
12,607
+11,881
| +1,637% | +$3.9M | 0.02% | 706 |
|
|
2025
Q4 | $254K | Sell |
726
-14,328
| -95% | -$4.84M | ﹤0.01% | 3087 |
|
|
2025
Q3 | $4.86M | Sell |
15,054
-1,984
| -12% | -$617K | 0.02% | 1187 |
|
|
2025
Q2 | $6.63M | Sell |
17,038
-3,136
| -16% | -$1.26M | 0.03% | 833 |
|
|
2025
Q1 | $8.77M | Sell |
20,174
-6,533
| -24% | -$2.62M | 0.04% | 516 |
|
|
2024
Q4 | $9.85M | Buy |
26,707
+6,626
| +33% | +$2.77M | 0.04% | 530 |
|
|
2024
Q3 | $10.4M | Buy |
20,081
+13,838
| +222% | +$7.39M | 0.05% | 387 |
|
|
2024
Q2 | $3.38M | Sell |
6,243
-33,982
| -84% | -$18M | 0.02% | 965 |
|
|
2024
Q1 | $20.9M | Sell |
40,225
-116,167
| -74% | -$57.8M | 0.14% | 117 |
|
|
2023
Q4 | $73.7M | Buy |
156,392
+97,387
| +165% | +$45M | 0.58% | 14 |
|
|
2023
Q3 | $25.7M | Buy |
59,005
+11,579
| +24% | +$5.25M | 0.3% | 49 |
|
|
2023
Q2 | $21.1M | Buy |
47,426
+15,826
| +50% | +$7.3M | 0.28% | 78 |
|
|
2023
Q1 | $14.5M | Buy |
31,600
+9,356
| +42% | +$4.45M | 0.2% | 126 |
|
|
2022
Q4 | $11.4M | Sell |
22,244
-2,157
| -9% | -$1.1M | 0.18% | 126 |
|
|
2022
Q3 | $11.1M | Buy |
24,401
+18,023
| +283% | +$8.62M | 0.12% | 196 |
|
|
2022
Q2 | $3.08M | Buy |
6,378
+690
| +12% | +$341K | 0.06% | 440 |
|
|
2022
Q1 | $2.79M | Sell |
5,688
-7,355
| -56% | -$3.36M | 0.03% | 733 |
|
|
2021
Q4 | $6.05M | Sell |
13,043
-4,332
| -25% | -$1.82M | 0.04% | 294 |
|
|
2021
Q3 | $6.48M | Buy |
17,375
+8,721
| +101% | +$3.31M | 0.06% | 224 |
|
|
2021
Q2 | $3.3M | Sell |
8,654
-8,481
| -49% | -$3.24M | 0.03% | 343 |
|
|
2021
Q1 | $6.15M | Sell |
17,135
-4,334
| -20% | -$1.39M | 0.07% | 162 |
|
|
2020
Q4 | $6.89M | Buy |
21,469
+847
| +4% | +$260K | 0.06% | 170 |
|
|
2020
Q3 | $5.54M | Sell |
20,622
-3,481
| -14% | -$937K | 0.11% | 120 |
|
|
2020
Q2 | $6.34M | Buy |
24,103
+9,461
| +65% | +$2.52M | 0.21% | 83 |
|
|
2020
Q1 | $3.32M | Sell |
14,642
-22,491
| -61% | -$6.13M | 0.13% | 116 |
|
|
2019
Q4 | $11.2M | Buy |
37,133
+13,652
| +58% | +$3.76M | 0.2% | 85 |
|
|
2019
Q3 | $5.64M | Buy |
23,481
+9,281
| +65% | +$2.54M | 0.16% | 101 |
|
|
2019
Q2 | $4.01M | Buy |
14,200
+8,678
| +157% | +$2.37M | 0.11% | 131 |
|
|
2019
Q1 | $1.58M | Buy |
+5,522
| New | +$1.6M | 0.06% | 276 |
|
|
2018
Q3 | – | Sell |
-29,948
| Closed | -$7.13M | – | 1296 |
|
|
2018
Q2 | $7.13M | Buy |
29,948
+24,646
| +465% | +$5.71M | 0.44% | 34 |
|
|
2018
Q1 | $1.17M | Buy |
5,302
+1,318
| +33% | +$310K | 0.09% | 314 |
|
|
2017
Q4 | $896K | Sell |
3,984
-15,155
| -79% | -$3.23M | 0.08% | 284 |
|
|
2017
Q3 | $3.63M | Sell |
19,139
-9,800
| -34% | -$1.87M | 0.29% | 57 |
|
|
2017
Q2 | $5.44M | Sell |
28,939
-567
| -2% | -$102K | 0.53% | 34 |
|
|
2017
Q1 | $4.88M | Sell |
29,506
-4,441
| -13% | -$706K | 0.46% | 29 |
|
|
2016
Q4 | $4.88M | Sell |
33,947
-15,417
| -31% | -$2.06M | 0.42% | 23 |
|
|
2016
Q3 | $6.19M | Buy |
49,364
+10,478
| +27% | +$1.35M | 0.66% | 14 |
|
|
2016
Q2 | $5.11M | Buy |
38,886
+23,971
| +161% | +$3.28M | 0.65% | 22 |
|
|
2016
Q1 | $2.07M | Sell |
14,915
-1,605
| -10% | -$214K | 0.34% | 55 |
|
|
2015
Q4 | $2.3M | Buy |
+16,520
| New | +$2.28M | 0.44% | 51 |
|
|
2015
Q2 | – | Sell |
-1,728
| Closed | -$267K | – | 643 |
|
|
2015
Q1 | $267K | Buy |
+1,728
| New | +$246K | 0.03% | 238 |
|
|
2014
Q4 | – | Sell |
-6,922
| Closed | -$828K | – | 440 |
|
|
2014
Q3 | $828K | Sell |
6,922
-86
| -1% | -$9.86K | 0.12% | 143 |
|
|
2014
Q2 | $754K | Sell |
7,008
-18,732
| -73% | -$1.93M | 0.08% | 162 |
|
|
2014
Q1 | $2.56M | Buy |
25,740
+23,010
| +843% | +$2.08M | 0.39% | 43 |
|
|
2013
Q4 | $252K | Sell |
2,730
-5,924
| -68% | -$526K | 0.04% | 316 |
|
|
2013
Q3 | $724K | Buy |
+8,654
| New | +$742K | 0.11% | 153 |
|
Other funds holding ELV
VCM
VPM
Verition Fund Management's ELV Position: Q1 2026 in Review
Verition Fund Management increased its Elevance Health (ELV) stake by 1,637% in Q1 2026, buying an estimated $3.9M and bringing the position to 12,607 shares worth $3.69M. The position accounts for 0.02% of the portfolio, ranked #706.
Verition Fund Management first reported a position in ELV in Q3 2013 and has held it in 46 quarters since. The position peaked at $73.7M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Verition Fund Management held 12,607 shares of Elevance Health worth $3.69M as of Q1 2026.
- Verition Fund Management bought 11,881 Elevance Health shares in Q1 2026, an estimated $3.9M.
- Elevance Health made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #706 holding.
- Verition Fund Management first reported a position in Elevance Health in Q3 2013 and has held it in 46 quarters since.
- Verition Fund Management's Elevance Health position peaked at $73.7M in Q4 2023.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.